Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cyclizine hydrochloride 50mg - tablet - 50 mg - active: cyclizine hydrochloride 50mg excipient: acacia lactose monohydrate magnesium stearate potato starch - nausicalm is indicated for the prevention and treatment of nausea and vomiting including motion sickness, nausea and vomiting caused by narcotic analgesics and by general anaesthetics in the post-operative period and radiotherapy, especially for breast cancer since cyclizine does not elevate prolactin levels. nausicalm may be of value in relieving vomiting and attacks of vertigo associated with meniere's disease and other forms of vestibular disturbance.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - cyclizine lactate, quantity: 50 mg/ml - injection - excipient ingredients: lactic acid; water for injections - valoid is indicated for the prevention of nausea and vomiting in the post operative period

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

amdipharm plc - cyclizine hydrochloride - oral tablet - 50mg

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - cyclizine lactate - solution for injection - 50mg/1ml

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

amdipharm plc - cyclizine hydrochloride; dipipanone hydrochloride - oral tablet - 30mg ; 10mg

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

haleon uk ltd - aspirin; paracetamol; caffeine - oral tablet - 300mg ; 200mg ; 45mg

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - cyclizine lactate - solution for injection - 50mg/1ml

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

ethypharm - cyclizine - solution for injection - 50 milligram(s)/millilitre - piperazine derivatives; cyclizine

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

max health limited - cyclizine 37.35 mg/ml equivalent to 50 mg/ml cyclizine lactate - solution for injection - 50 mg/ml - active: cyclizine 37.35 mg/ml equivalent to 50 mg/ml cyclizine lactate excipient: lactic acid water for injection - cyclizine is indicated for the prevention and treatment of nausea and vomiting including: motion sickness, nausea and vomiting caused by narcotic analgesics and by general anaesthetics in the post- operative period; vomiting associated with radiotherapy, especially for breast cancer since cyclizine does not elevate prolactin levels. intravenous cyclizine lactate is indicated pre-operatively in patients undergoing emergency surgery to reduce the hazard of regurgitation and aspiration of gastric contents during induction of general anaesthesia. cyclizine lactate may be of value in relieving vomiting and attacks of vertigo associated with meniere's disease and other forms of vestibular disturbance.

África do Sul - inglês - South African Health Products Regulatory Authority (SAHPRA)

medpro pharmaceutica (pty) ltd - syrup - see ingredients - 5 ml cyclizine hydrochloride 12,5 mg